Sector consensus Sensei Biotherapeutics, Inc.
Stocks
SNSE
US81728A2078
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.94 USD | +4.65% |
|
-27.71% | +12.46% |
| 07:17am | BTIG Research Initiates Coverage on Sensei Biotherapeutics With Buy Rating, $55 Price Target | MT |
| May. 29 | Cantor Fitzgerald Initiates Sensei Biotherapeutics at Overweight | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | 51.67 | +352.82% | 3 | |||||
| 846.68 | +10.97% | 15 | ||||||
| 145.96 | +50.41% | 16 | ||||||
| 106.48 | +43.68% | 19 | ||||||
| 198.1 | +115.6% | 21 | ||||||
| 40.49 | +57.97% | 22 | ||||||
| 2,313.13 | +43.85% | 15 | ||||||
| 49 | -6.81% | 16 | ||||||
| 810.5 | -17.8% | 6 | ||||||
| 547.64 | +36.43% | 17 | ||||||
| 21.28 | +118.4% | 13 | ||||||
| 679.29 | +44.12% | 14 | ||||||
| 148.87 | +95.8% | 20 | ||||||
| 88.17 | +24.65% | 12 | ||||||
| 128.41 | +4.1% | 17 | ||||||
| 104.7 | +56.11% | 20 | ||||||
| 13 | +86.25% | 3 | ||||||
| 99.79 | +64.9% | 15 | ||||||
| 414.05 | -0.13% | 20 | ||||||
| - | - | 770,000 | +83.77% | 1 | ||||
| Average | 38,840.36 | +63.25% | 14 | ||||||
| Weighted average by Cap. | 18,271.76 | +43.57% | 16 |
- Stock Market
- Stocks
- SNSE Stock
- Sector Sensei Biotherapeutics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
